Dermatitis, atopic Trials in Markham, Canada
Conditions / Dermatitis, atopic / Markham, Canada
Dermatitis, atopic is a medical condition with active clinical research programs worldwide.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05492578 | Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials | ENROLLING_BY_INVITATION | PHASE2/PHASE3 |
| NCT03720470 | Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy | COMPLETED | PHASE3 |
| NCT03422822 | Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT06407934 | A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03687359 | Observational Evaluation of Atopic Dermatitis in Pediatric Patients | ACTIVE_NOT_RECRUITING | — |
| NCT03428646 | Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | — |
| NCT06224348 | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids | COMPLETED | PHASE3 |
| NCT03349060 | Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT03627767 | Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects | COMPLETED | PHASE3 |
| NCT05999799 | A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis | TERMINATED | PHASE2 |